Teladoc Health (NYSE:TDOC) Shares Up 5.7%

Teladoc Health Inc (NYSE:TDOC) shares shot up 5.7% during trading on Friday . The stock traded as high as $66.56 and last traded at $66.41. 2,501,293 shares traded hands during trading, an increase of 77% from the average session volume of 1,417,055 shares. The stock had previously closed at $62.82.

Several research firms recently issued reports on TDOC. ValuEngine downgraded shares of Teladoc Health from a “strong-buy” rating to a “buy” rating in a report on Friday, June 14th. Zacks Investment Research raised shares of Teladoc Health from a “sell” rating to a “hold” rating in a report on Monday, April 1st. Stephens began coverage on shares of Teladoc Health in a report on Tuesday, April 16th. They set an “overweight” rating and a $75.00 price objective for the company. Cantor Fitzgerald reaffirmed a “hold” rating and set a $70.00 price objective on shares of Teladoc Health in a report on Tuesday, April 30th. Finally, Bank of America began coverage on shares of Teladoc Health in a report on Thursday, June 13th. They set a “buy” rating and a $65.00 price objective for the company. Three analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has given a strong buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus target price of $82.68.

The company has a quick ratio of 7.54, a current ratio of 7.54 and a debt-to-equity ratio of 0.42. The stock’s fifty day simple moving average is $59.71. The company has a market capitalization of $4.75 billion, a PE ratio of -46.12 and a beta of 1.26.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings results on Tuesday, April 30th. The health services provider reported ($0.43) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.44) by $0.01. Teladoc Health had a negative net margin of 22.63% and a negative return on equity of 10.86%. The firm had revenue of $128.57 million during the quarter, compared to the consensus estimate of $127.99 million. During the same period in the prior year, the firm earned ($0.39) EPS. The business’s revenue was up 43.4% on a year-over-year basis. Equities analysts anticipate that Teladoc Health Inc will post -1.53 EPS for the current year.

In other news, SVP Andrew Turitz sold 31,960 shares of the firm’s stock in a transaction dated Thursday, April 4th. The shares were sold at an average price of $55.82, for a total transaction of $1,784,007.20. Following the completion of the transaction, the senior vice president now directly owns 13,455 shares of the company’s stock, valued at approximately $751,058.10. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Lewis Levy sold 675 shares of the firm’s stock in a transaction dated Monday, June 17th. The stock was sold at an average price of $60.00, for a total transaction of $40,500.00. Following the transaction, the insider now directly owns 4,805 shares of the company’s stock, valued at $288,300. The disclosure for this sale can be found here. Insiders have sold a total of 144,542 shares of company stock valued at $8,285,951 over the last ninety days. 3.95% of the stock is owned by insiders.

Several large investors have recently added to or reduced their stakes in TDOC. Janus Henderson Group PLC lifted its holdings in shares of Teladoc Health by 87.2% during the 1st quarter. Janus Henderson Group PLC now owns 2,989,090 shares of the health services provider’s stock worth $166,197,000 after acquiring an additional 1,391,969 shares during the period. Vanguard Group Inc increased its position in shares of Teladoc Health by 26.9% during the 3rd quarter. Vanguard Group Inc now owns 5,874,182 shares of the health services provider’s stock worth $507,236,000 after purchasing an additional 1,244,388 shares in the last quarter. Norges Bank acquired a new stake in shares of Teladoc Health during the 4th quarter worth about $32,112,000. Macquarie Group Ltd. increased its position in shares of Teladoc Health by 101.5% during the 4th quarter. Macquarie Group Ltd. now owns 1,125,275 shares of the health services provider’s stock worth $55,780,000 after purchasing an additional 566,839 shares in the last quarter. Finally, Bellevue Group AG increased its position in shares of Teladoc Health by 83.1% during the 4th quarter. Bellevue Group AG now owns 1,073,839 shares of the health services provider’s stock worth $53,230,000 after purchasing an additional 487,319 shares in the last quarter.

Teladoc Health Company Profile (NYSE:TDOC)

Teladoc Health, Inc provides telehealth services. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.

Further Reading: What are the FAANG Stocks?

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.